[HTML][HTML] Efficacy and blood plasmalogen changes by oral administration of plasmalogen in patients with mild Alzheimer's disease and mild cognitive impairment: a …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - …, 2017 - thelancet.com
Abstract Background Plasmalogens (Pls) reportedly decreased in postmortem brain and in
the blood of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal …

[PDF][PDF] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana - 2017 - reoken.com
Takehiko Fujino a,⁎, Tatsuo Yamada b, Takashi Asada c, Yoshio Tsuboi d, Chikako Wakana
e, Shiro Mawatari a, Suminori Kono fa Institute of Rheological Functions of Food, 2241-1 …

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - EBioMedicine, 2017 - infona.pl
Plasmalogens (Pls) reportedly decreased in postmortem brain and in the blood of patients
with Alzheimer's disease (AD). Recently we showed that intraperitoneal administration of Pls …

[PDF][PDF] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana - 2017 - naturalhealthresearch.org
Takehiko Fujino a,⁎, Tatsuo Yamada b, Takashi Asada c, Yoshio Tsuboi d, Chikako Wakana
e, Shiro Mawatari a, Suminori Kono fa Institute of Rheological Functions of Food, 2241-1 …

[HTML][HTML] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - EBioMedicine, 2017 - Elsevier
Abstract Background Plasmalogens (Pls) reportedly decreased in postmortem brain and in
the blood of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal …

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - Ebiomedicine, 2017 - europepmc.org
Background Plasmalogens (Pls) reportedly decreased in postmortem brain and in the blood
of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal …

[PDF][PDF] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana - 2017 - stop-alz.com
Takehiko Fujino a,⁎, Tatsuo Yamada b, Takashi Asada c, Yoshio Tsuboi d, Chikako Wakana
e, Shiro Mawatari a, Suminori Kono fa Institute of Rheological Functions of Food, 2241-1 …

Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - 2017 - pubmed.ncbi.nlm.nih.gov
Background Plasmalogens (Pls) reportedly decreased in postmortem brain and in the blood
of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal …

[PDF][PDF] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana - 2017 - scienceopen.com
Takehiko Fujino a,⁎, Tatsuo Yamada b, Takashi Asada c, Yoshio Tsuboi d, Chikako Wakana
e, Shiro Mawatari a, Suminori Kono fa Institute of Rheological Functions of Food, 2241-1 …

[HTML][HTML] Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A …

T Fujino, T Yamada, T Asada, Y Tsuboi, C Wakana… - …, 2017 - ncbi.nlm.nih.gov
Background Plasmalogens (Pls) reportedly decreased in postmortem brain and in the blood
of patients with Alzheimer's disease (AD). Recently we showed that intraperitoneal …